Medicare Enrolled
Dr. Lewis Attas, M.D.
Optician · Englewood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Attas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Attas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Attas
Dr. Lewis Attas is an optician specialist in Englewood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Attas performed 4,613 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Attas received a total of $5,643 from 52 pharmaceutical and/or device companies across 269 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Attas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 15% volume in NJ
$5,643 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,613
Medicare services
Top 15% in NJ for optician
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,807 | $5 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,280 | $106 | $240 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
422 | $150 | $325 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
291 | $76 | $165 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
254 | $68 | $160 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
116 | $12 | $70 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
113 | $1 | $5 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
83 | $104 | $230 |
| New patient office visit, complex (60-74 min) | 72 | $178 | $460 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
61 | $34 | $70 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
58 | $22 | $30 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $113 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $151 | $445 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
17 | $4 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,643
Total received (2018-2024)
Avg $806/year across 7 years
Top 15% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
269
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,717
2023
$1,010
2022
$737
2021
$493
2020
$159
2019
$302
2018
$1,226
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$382
Alexion Pharmaceuticals, Inc.
$290
Merck Sharp & Dohme LLC
$201
GENZYME CORPORATION
$146
Amgen Inc.
$135
Blueprint Medicines Corporation
$89
PFIZER INC.
$70
AstraZeneca Pharmaceuticals LP
$59
Tempus AI, Inc
$50
Aveo Pharmaceuticals, Inc.
$36
Celgene Corporation
$34
Janssen Biotech, Inc.
$34
ABBVIE INC.
$32
Novocure Inc.
$28
Exelixis Inc.
$23
Genentech USA, Inc.
$22
ARRAY BIOPHARMA INC
$18
E.R. Squibb & Sons, L.L.C.
$18
JAZZ PHARMACEUTICALS INC.
$17
Incyte Corporation
$16
Lilly USA, LLC
$16
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$873
Amgen Inc.
$550
Incyte Corporation
$465
AstraZeneca Pharmaceuticals LP
$364
Alexion Pharmaceuticals, Inc.
$304
Novocure GmbH
$250
Daiichi Sankyo Inc.
$237
Merck Sharp & Dohme LLC
$219
GENZYME CORPORATION
$206
Celgene Corporation
$196
Merck Sharp & Dohme Corporation
$158
Janssen Biotech, Inc.
$154
E.R. Squibb & Sons, L.L.C.
$143
PFIZER INC.
$142
NOVARTIS PHARMACEUTICALS CORPORATION
$138
Genentech USA, Inc.
$108
Blueprint Medicines Corporation
$89
SANOFI-AVENTIS U.S. LLC
$86
Lilly USA, LLC
$72
Bayer HealthCare Pharmaceuticals Inc.
$57
Tempus AI, Inc
$50
Myriad Genetic Laboratories, Inc.
$48
Otsuka America Pharmaceutical, Inc.
$42
MorphoSys, US Inc.
$40
Gilead Sciences, Inc.
$40
Takeda Pharmaceuticals U.S.A., Inc.
$39
Foundation Medicine, Inc.
$37
Aveo Pharmaceuticals, Inc.
$36
ABBVIE INC.
$32
Astellas Pharma US Inc
$30
EMD Serono, Inc.
$29
Novocure Inc.
$28
Ipsen Biopharmaceuticals, Inc
$28
Regeneron Healthcare Solutions, Inc.
$27
Janssen Pharmaceuticals, Inc
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$24
Exelixis Inc.
$23
Mirati Therapeutics, Inc.
$22
Pharmacosmos Therapeutics Inc.
$19
Advanced Accelerator Applications
$18
ARRAY BIOPHARMA INC
$18
Veloxis Pharmaceuticals, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
BeiGene USA, Inc.
$15
EISAI INC.
$15
Acrotech Biopharma LLC
$15
Seagen Inc.
$15
Alfasigma USA, Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
CTI BioPharma Corp.
$14
Eisai Inc.
$13
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AYVAKIT · Abraxane · Avastin · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · DARZALEX · ELAHERE · ELITEK · ENHERTU · ENVARSUS · Enhertu · Erivedge · Erleada · FASLODEX · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · HEMADY · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LUMAKRAS · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nexavar · Nubeqa · ONUREG · OPDIVO · Optune · PADCEV · PIQRAY · PRECISETUMOR · PROMACTA · Perjeta · Pomalyst · Prolia · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SOLIRIS · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · ULTOMIRIS · VERZENIO · Venclexta · Vonjo · XALKORI · XARELTO · XTANDI · Xofigo · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
15,382
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Attas is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Attas experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Attas performed 1,807 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Attas receive payments from pharmaceutical companies?
Yes. Dr. Attas received a total of $5,643 from 52 companies across 269 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Attas's costs compare to other opticians in Englewood?
Dr. Attas's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Attas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Englewood
Browse opticians in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology